| Q56908839 | A primer on strategies for prevention and control of seasonal and pandemic influenza |
| Q38492992 | A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older |
| Q47601372 | A retrospective observational analysis of post-pandemic influenza-related outcomes in the United Kingdom, 2010-2014. |
| Q41653100 | Absenteeism among hospital staff during an influenza epidemic: implications for immunoprophylaxis. |
| Q36896556 | Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children |
| Q34162028 | Acute lower respiratory tract infections in nonhospitalized children |
| Q30361180 | Analyses of the 1957 (Asian) influenza pandemic in the United Kingdom and the impact of school closures. |
| Q34714853 | Animal Models for Influenza Virus Pathogenesis and Transmission |
| Q27024582 | Animal models for influenza virus pathogenesis, transmission, and immunology |
| Q30358892 | Asymptomatic ratio for seasonal H1N1 influenza infection among schoolchildren in Taiwan. |
| Q34475023 | Burden of paediatric influenza in Western Europe: a systematic review |
| Q33603662 | Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children |
| Q34460383 | Cold-attenuated live influenza vaccines, a risk-benefit assessment |
| Q33950811 | Community respiratory viruses in individuals with human immunodeficiency virus infection |
| Q30388381 | Contagious period for pandemic (H1N1) 2009. |
| Q44276981 | Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States |
| Q30375776 | Does influenza transmission occur from asymptomatic infection or prior to symptom onset? |
| Q33526047 | Duration of shedding of respiratory syncytial virus in a community study of Kenyan children |
| Q28749090 | Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China |
| Q40152886 | Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial |
| Q36566014 | Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study |
| Q41518340 | Epidemiology, pathogenesis, and treatment of the common cold |
| Q36759964 | Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign |
| Q50984534 | Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. |
| Q34194686 | Evaluation of a new dot blot enzyme immunoassay (directigen flu A+B) for simultaneous and differential detection of influenza a and B virus antigens from respiratory samples. |
| Q40345154 | Feasibility of diagnosing influenza within 24 hours of symptom onset in children 1-3 years of age. |
| Q34706374 | Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors |
| Q35857995 | Growth of influenza A virus in primary, differentiated epithelial cells derived from adenoids |
| Q34212799 | Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the |
| Q36021208 | Health outcome and safety assessment of a fixed dose combination of Amantadine, Paracetamol, Chlorpheniramine maleate, and Phenylephrine introduction in India: A prescription event monitoring study |
| Q30383991 | Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. |
| Q34305125 | How to minimize the attack rate during multiple influenza outbreaks in a heterogeneous population |
| Q36540051 | Identification of a variant subgroup A strain of respiratory syncytial virus |
| Q34733946 | Infectious diseases in day-care centres: minimizing the risk |
| Q35544259 | Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding. |
| Q39425079 | Influenza in long-term care facilities |
| Q30309203 | Influenza in the acute hospital setting |
| Q90525157 | Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children |
| Q37298227 | Innate sensors of influenza virus: clues to developing better intranasal vaccines |
| Q40015381 | Isolation of highly fusogenic variants of simian virus 5 from persistently infected cells that produce and respond to interferon |
| Q69336695 | Isolation usage in a pediatric hospital |
| Q35880624 | Laboratory diagnosis of SARS. |
| Q55000683 | Management and control of communicable diseases in schools and other child care settings: systematic review on the incubation period and period of infectiousness. |
| Q46634771 | Microarray detection of human parainfluenzavirus 4 infection associated with respiratory failure in an immunocompetent adult |
| Q30230076 | Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning |
| Q42184718 | Multicluster nosocomial outbreak of parainfluenza virus type 3 infection in a pediatric oncohematology unit: a phylogenetic study |
| Q30353075 | Non-pharmaceutical interventions for pandemic influenza, international measures. |
| Q30385888 | Novel virus influenza A (H1N1sw) in South-Eastern France, April-August 2009. |
| Q34759825 | Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer |
| Q33720358 | Outpatient physician billing data for age and setting specific syndromic surveillance of influenza-like illnesses |
| Q30394197 | Pandemic H1N1 and seasonal H3N2 influenza infection in the human population show different distributions of viral loads, which substantially affect the performance of rapid influenza tests |
| Q45737985 | Parainfluenza virus type 3 infections in a hematology unit |
| Q24682952 | Parainfluenza viruses |
| Q41842259 | Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses |
| Q40362838 | Performance of rapid influenza testing in hospitalized children |
| Q35088115 | Positive network assortativity of influenza vaccination at a high school: implications for outbreak risk and herd immunity |
| Q30398281 | Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands |
| Q59351160 | Primary and Repeated Respiratory Viral Infections Among Infants in Rural Nepal |
| Q28365074 | Quantification and determinants of the amount of respiratory syncytial virus (RSV) shed using real time PCR data from a longitudinal household study |
| Q35128031 | Quantitative influenza follow-up testing (QIFT)--a novel biomarker for the monitoring of disease activity at the point-of-care |
| Q37071979 | Rapid detection of parainfluenza virus type 3 RNA in respiratory specimens: use of reverse transcription-PCR-enzyme immunoassay. |
| Q30407603 | Recommendations for and compliance with social restrictions during implementation of school closures in the early phase of the influenza A (H1N1) 2009 outbreak in Melbourne, Australia |
| Q35989482 | Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection |
| Q37061644 | Respiratory virus shedding in a cohort of on-duty healthcare workers undergoing prospective surveillance |
| Q30383429 | Role of rapid immunochromatographic antigen testing in diagnosis of influenza A virus 2009 H1N1 infection. |
| Q30220472 | Routes of influenza transmission |
| Q35268325 | Routine influenza vaccination for healthy children--old concept, new technologies |
| Q34137789 | School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance |
| Q48585293 | Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America |
| Q51128149 | Seroprevalence of influenza A and B in German infants and adolescents. |
| Q36348822 | Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts. |
| Q64374904 | Simulation of four respiratory viruses and inference of epidemiological parameters |
| Q42508246 | Suppression of lymphocyte proliferation by parainfluenza virus type 3-infected bovine alveolar macrophages |
| Q38448647 | Surveillance of childhood influenza virus infection: what is the best diagnostic method to use for archival samples? |
| Q37074844 | Symptomatic parainfluenza virus infections in children undergoing hematopoietic stem cell transplantation |
| Q30356326 | Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age. |
| Q39523163 | Targeted vaccination in healthy school children - Can primary school vaccination alone control influenza? |
| Q30379159 | The Evolutionary Dynamics of Stochastic Epidemic Model with Nonlinear Incidence Rate. |
| Q36792008 | The Timeline of Influenza Virus Shedding in Children and Adults in a Household Transmission Study of Influenza in Managua, Nicaragua |
| Q30350751 | The impact of influenza on the health and health care utilisation of elderly people. |
| Q28743825 | The population impact of a large school-based influenza vaccination campaign |
| Q30429917 | The serial intervals of seasonal and pandemic influenza viruses in households in Bangkok, Thailand |
| Q39429254 | Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness |
| Q56834154 | Traveling waves in a model of influenza A drift |
| Q30404708 | Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom |
| Q35108669 | Using mathematical transmission modelling to investigate drivers of respiratory syncytial virus seasonality in children in the Philippines |
| Q36964157 | Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons |
| Q40137288 | Viral Respiratory Illnesses |
| Q30367126 | What the paediatrician needs to know when pandemic influenza arrives in clinical practice. |
| Q80025027 | [Infection by influenza virus in childhood: a call for broader influenza vaccination] |